New digital outreach aims to prevent diabetes in moms after pregnancy
NCT ID NCT05752292
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests an online program to help women who had gestational diabetes get the recommended diabetes screening and lifestyle programs after giving birth. The program includes standard health information plus optional interactive components like values reflection and personalized risk feedback. Researchers will enroll 2,000 women to see which combination works best to increase screening rates and prevent type 2 diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
digital health outreach intervention (standard health information, values affirmation, tailored risk information, motivational interviewing, action planning)
What this could lead to
If successful, this could provide a scalable way to increase postpartum diabetes testing and lifestyle program uptake, helping prevent type 2 diabetes in women who had gestational diabetes.
What could go wrong
This is a behavioral intervention trial, not a drug or device study. The effects may be modest, and results may not generalize beyond the specific health system and English-speaking participants involved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaiser Permanente Northern California
Pleasanton, California, 94588, United States